NCT03381404View on ClinicalTrials.gov

Mass Balance Study With MT-8554

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

January 29, 2018

Study Completion Date

January 29, 2018

Conditions
Healthy Volunteer
Interventions
DRUG

[14C] MT-8554

14-C MT-8554

Trial Locations (1)

Unknown

Investigational center, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY